Philosys' blood glucose meter goes mobile with new FDA approval

NEW YORK - Philosys, the maker of Gmate products, announced Wednesday that the U.S. Food and Drug Administration has approved clearance for the Gmate SMART Blood Glucose Monitoring System and App for Android. The Gmate SMART is a small, portable blood glucose meter that plugs into the headphone jack of a smartphone and provides blood glucose test results. 

 

Together, the Gmate SMART Meter and App turn a smartphone into a mobile blood glucose monitoring system.

 

"As cloud technology grows, Philosys is working to create an App-to-Cloud secure connection in the next generation of updates," stated Mike Tickle, SVP sales Philosys. This will allow for improved communication and notifications between patients and physicians, he said. "Not only is Gmate SMART changing diabetes care by improving health and lifestyle, but it's also affordable. Most retail pharmacies are selling both the meter and box of 50 count strips at a low cost."

 

The FDA approval of Gmate SMART for Android is another important milestone for Philosys. The Gmate SMART App is now available for both iOS and Android users. This is the next critical step for Gmate mHealth technology, the company stated.

 

The Gmate SMART Meter is the size of a quarter and connects to the headphone jack of the smartphone. The Gmate SMART App integrates diabetes management directly to the iOS and Android device, providing diabetes management tools including goal setting, graphing and the ability to email or text blood glucose test results directly to a family member or healthcare provider. 

 

The Gmate SMART App stores an unlimited number of test results electronically with the date and time. A user can also add custom comments, actions or notes to each test result.